journal article Open Access Jun 01, 2019

Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy

EBioMedicine Vol. 44 pp. 289-297 · Elsevier BV
View at Publisher Save 10.1016/j.ebiom.2019.05.023
Topics

No keywords indexed for this article. Browse by subject →

References
36
[1]
Chen "Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer" BMC Cancer (2013) 10.1186/1471-2407-13-539
[2]
Li "Value of sequential 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in prediction of the overall survival of esophageal cancer patients treated with chemoradiotherapy" Int J Clin Exp Med (2015)
[3]
Atsumi "Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer" J Radiat Res (2013) 10.1093/jrr/rrt021
[4]
Lindner "PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer" Langenbecks Arch Surg (2015) 10.1007/s00423-014-1264-9
[5]
Myslivecek Czechoslovakia (2012)
[7]
Beukinga "Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pretreatment (18)F-FDG PET/CT imaging" J Nucl Med (2017) 10.2967/jnumed.116.180299
[8]
Hou "Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma" Oncotarget (2017) 10.18632/oncotarget.22304
[9]
Ganeshan "Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage" Cancer Imaging (2010) 10.1102/1470-7330.2010.0021
[10]
Ganeshan "Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival" Clin Radiol (2012) 10.1016/j.crad.2011.08.012
[11]
Gatenby "Quantitative imaging in cancer evolution and ecology" Radiology (2013) 10.1148/radiol.13122697
[12]
Wu "Intratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy" Radiology (2018) 10.1148/radiol.2018172462
[13]
Wu "Robust Intratumor partitioning to identify high-risk subregions in lung cancer: a pilot study" Int J Radiat Oncol Biol Phys (2016) 10.1016/j.ijrobp.2016.03.018
[14]
Xia "Radiogenomics of hepatocellular carcinoma: multiregion analysis-based identification of prognostic imaging biomarkers by integrating gene data-a preliminary study" Phys Med Biol (2018) 10.1088/1361-6560/aaa609
[15]
Liu "Understanding and enhancement of internal clustering validation measures" IEEE Trans Cybern (2013) 10.1109/tsmcb.2012.2220543
[16]
Larue "Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study" Acta Oncol (2017) 10.1080/0284186x.2017.1351624
[17]
Vallieres "El Naqa I. a radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities" Phys Med Biol (2015) 10.1088/0031-9155/60/14/5471
[18]
Parada "Accuracy and reliability of a simple calculation for measuring glenoid bone loss on 3-dimensional computed tomography scans" Arthroscopy (2018) 10.1016/j.arthro.2017.07.032
[19]
Huang "Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer" Radiology (2016) 10.1148/radiol.2016152234
[20]
Liang "Novel nomogram for preoperative prediction of early recurrence in intrahepatic cholangiocarcinoma" Front Oncol (2018) 10.3389/fonc.2018.00360
[21]
Park "Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer" Clin Cancer Res (2018) 10.1158/1078-0432.ccr-17-3783
[22]
Hu "A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules" Eur Radiol (2019) 10.1007/s00330-018-5539-3
[23]
Wu "Survival prediction in high-grade osteosarcoma using radiomics of diagnostic computed tomography" EBioMedicine (2018) 10.1016/j.ebiom.2018.07.006
[24]
Fast and accurate short read alignment with Burrows–Wheeler transform

Heng Li, Richard Durbin

Bioinformatics 2009 10.1093/bioinformatics/btp324
[25]
cn.MOPS: mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate

Günter Klambauer, Karin Schwarzbauer, Andreas Mayr et al.

Nucleic Acids Research 2012 10.1093/nar/gks003
[26]
Wald "Future directions in esophageal cancer therapy" Ann Cardiothorac Surg (2017) 10.21037/acs.2017.02.01
[27]
Abdo "Targeted” chemotherapy for esophageal cancer" Front Oncol (2017) 10.3389/fonc.2017.00063
[28]
Bolm "Multimodal anti-tumor approaches combined with immunotherapy to overcome tumor resistance in esophageal and gastric cancer" Anticancer Res (2018) 10.21873/anticanres.12588
[29]
Segal "Decoding global gene expression programs in liver cancer by noninvasive imaging" Nat Biotechnol (2007) 10.1038/nbt1306
[30]
Aerts "Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach" Nat Commun (2014) 10.1038/ncomms5006
[31]
Grossmann "Defining the biological basis of radiomic phenotypes in lung cancer" eLife (2017)
[32]
Wilson "Radiomics of pulmonary nodules and lung cancer" Transl Lung Cancer Res (2017) 10.21037/tlcr.2017.01.04
[33]
Puli "Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review" World J Gastroenterol (2008) 10.3748/wjg.14.1479
[34]
Thosani "Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis" Gastrointest Endosc (2012) 10.1016/j.gie.2011.09.016
[35]
Wang "Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma" Hum Genomics (2015) 10.1186/s40246-015-0044-0
[36]
Wu "Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer" Eur J Cancer (2018) 10.1016/j.ejca.2018.01.085
Related

You May Also Like

Role of gut microbiota in type 2 diabetes pathophysiology

Manoj Gurung, Zhipeng Li · 2020

1,478 citations

Biological Age Predictors

Juulia Jylhävä, Nancy L. Pedersen · 2017

1,119 citations

Cellular Senescence: A Translational Perspective

James L. Kirkland, Tamara Tchkonia · 2017

911 citations